Table 2.
Comparison of clinical features of study participants by PSN status.
| No PSN (n = 292) | PSN (n = 58) | p | |
|---|---|---|---|
| Age (yrs) | 54.3 ± 10.2 | 52.6 ± 10.4 | 0.529 |
| Females, n (%) | 154 (52.7) | 21 (36.2) | 0.063 |
| Diabetes, n (%) | 193 (66.1) | 47 (81) | 0.011 |
| Hypertension, n (%) | 117 (50) | 35 (60.3) | 0.032 |
| Duration of diabetes | 7.7 ± 6.6 | 14.8 ± 6.8 | 0.001 |
| Previous smoking, n (%) | 38 (13) | 13 (22.4) | 0.15 |
| Weight (kg) | 79 ± 14.9 | 84 ± 15 | 0.215 |
| Height (cm) | 165 ± 8 | 175 ± 7 | <0.001 |
| BMI (kg/m2) | 29.2 ± 5.7 | 27.6 ± 5.2 | 0.257 |
| Body fat (%) | 35.1 ± 12.6 | 28 ± 11.5 | 0.037 |
| Visceral fat (%) | 11.2 ± 4.1 | 12.4 ± 6 | 0.324 |
| Waist circumference (cm) | 98 ± 13 | 98 ± 12 | 0.892 |
| Waist-hip ratio | 0.91 ± 0.1 | 0.92 ± 0.05 | 0.825 |
| Systolic BP (mmHg) | 138 ± 30 | 154 ± 18 | 0.006 |
| Diastolic BP (mmHg) | 82 ± 13 | 87 ± 15 | 0.176 |
| Pulse BP (mmHg) | 58 ± 14 | 66 ± 8 | 0.002 |
| Heart rate (bpm) | 70 ± 17 | 80 ± 7 | <0.001 |
| FPG (mmol/l) | 6.9 ± 3.3 | 6.5 ± 1.9 | 0.387 |
| Triglycerides (mmol/l) | 1.1 ± 0.5 | 1 ± 0.4 | 0.205 |
| Total cholesterol (mmol/l) | 4.7 ± 1.4 | 4.5 ± 1.8 | 0.506 |
| HDL cholesterol (mmol/l) | 0.7 ± 0.2 | 0.7 ± 0.3 | 0.913 |
| LDL cholesterol (mmol/l) | 3.3 ± 1.4 | 3.2 ± 1.5 | 0.825 |